Veeva Systems Inc.
VEEV Healthcare Health Information Services
Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.
Follow VEEV
Veeva Systems Inc. (VEEV) Total debt
Veeva Systems Inc.'s total debt at the end of fiscal 2023 was $61.0M, up 10.9% from $55.0M in fiscal 2022. At the end of the quarter to 31 October 2023 it was $58.0M. Veeva Systems Inc. ranks 20th of 49 Health Information Services companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2023 | $61.0M | 10.91% |
| FY2022 | $55.0M | (12.70%) |
| FY2021 | $63.0M | 14.55% |
| FY2020 | $55.0M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Oct 2023 | $58.0M | (1.69%) |
| Jul 2023 | $59.0M | 1.72% |
| Apr 2023 | $58.0M | (4.92%) |
| Jan 2023 | $61.0M | (1.61%) |
| 15 more quarters | Free account |
Total debt against peers
| Company | Total debt |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | $2.2B |
| WAY Waystar Holding Corp. compare | $1.5B |
| TEM Tempus AI, Inc. compare | $1.4B |
| HQY HealthEquity, Inc. compare | $931.1M |
| HTFL Heartflow, Inc. compare | $182.4M |
| TXG 10x Genomics compare | $98.0M |
| VEEV Veeva Systems Inc. | $58.0M |
| DOCS Doximity, Inc. compare | $15.0M |
| HNGE Hinge Health Inc. compare | — |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on VEEV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement